by Jessica Casebolt | Jun 22, 2023 | Life Sciences, Tea Leaves
The pharmaceutical industry’s largest trade group has filed a lawsuit challenging the constitutionality of President Biden’s drug-price negotiation law, the latest legal test of a program that could cost drugmakers billions of dollars over the next decade. The...
by Jessica Casebolt | Jun 20, 2023 | Life Sciences, Tea Leaves
The body mass index (BMI) metric has caused “historical harm,” including racist exclusion, according to a new report by the American Medical Association (AMA) Council on Science and Public Health. Doctors have long relied on BMI to measure obesity, but it...
by Jessica Casebolt | Jun 12, 2023 | Life Sciences, Tea Leaves
A panel of Food and Drug Administration advisers on Friday unanimously endorsed an experimental Alzheimer’s drug that’s been shown to have modest success slowing the progression of the disease, clearing a hurdle for full agency approval. Leqembi could...
by Jessica Casebolt | May 16, 2023 | Life Sciences, Tea Leaves
CVS Health is closing down its clinical trials arm just two years after its launch. The company began its collaboration with pharmaceutical companies in 2021 and will shut it down at the end of 2024. To date,CVS Health has worked with more than 30 drugmakers on 50...
by Jessica Casebolt | May 12, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration finalized new guidance on Thursday that will allow more gay and bisexual men to donate blo The change formally ends the FDA’s blood donor restrictionsfor men who have sex with men that originated during the HIV/AIDS crisis in the...
by Jessica Casebolt | May 11, 2023 | Life Sciences, Tea Leaves
A panel of outside advisers to the Food and Drug Administration (FDA) unanimously voted Wednesday that the benefits of making a birth control pill available over the counter outweigh the potential risks.The 17-0 vote represents a major step forward in the decades-long...
Recent Comments